Europe Gene Editing Market size was valued at USD 1 billion in 2019 and is expected to witness 14.9% CAGR from 2020 to 2026. Increasing R&D expenditures by pharmaceutical, research institutes, and biopharmaceutical companies will escalate the industry.

Europe Gene Editing Market Analysis & Forecast 2026 | Graphical Research

Europe Gene Editing Market Size By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), TALENs), By Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), By End-user (Biotech and Pharma Companies, Contract Research Organizations (CROs), Research Institutes), Industry Analysis Report, Country Outlook (UK, Germany, France, Spain, Russia, Italy, Poland, The Netherlands, Sweden), Application Potential, Competitive Market Share & Forecast, 2020 - 2026

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Definition and forecast parameters

1.1.1&nbsp;&nbsp;&nbsp; Definitions

1.1.2&nbsp;&nbsp;&nbsp; Methodology and forecast parameters

1.2&nbsp;&nbsp;&nbsp; Data sources

1.3&nbsp;&nbsp;&nbsp; References &amp; sources

1.3.1&nbsp;&nbsp;&nbsp; Secondary

1.3.2&nbsp;&nbsp;&nbsp; Primary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Europe gene editing industry summary, 2015 - 2026

2.1.1&nbsp;&nbsp;&nbsp; Country trends

2.1.2&nbsp;&nbsp;&nbsp; Application trends

2.1.3&nbsp;&nbsp;&nbsp; Technology trends

2.1.4&nbsp;&nbsp;&nbsp; End-user trends

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry outlook, 2015 - 2026

3.3&nbsp;&nbsp;&nbsp; Major factor analysis

3.3.1&nbsp;&nbsp;&nbsp; Drivers

3.3.1.1&nbsp;&nbsp;&nbsp; Rising R&amp;D expenditure and growth of biotechnology

3.3.1.2&nbsp;&nbsp;&nbsp; Increased funding for genetic research in Europe

3.3.1.3&nbsp;&nbsp;&nbsp; Technology advancements in gene editing

3.3.1.4&nbsp;&nbsp;&nbsp; Increasing demand for synthetic genes in Europe

3.3.2&nbsp;&nbsp;&nbsp; Restraints &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp; Stringent government regulations

3.3.2.2&nbsp;&nbsp;&nbsp; Lack of public awareness in underdeveloped economies

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.6&nbsp;&nbsp;&nbsp; Competitive review, 2019

3.7&nbsp;&nbsp;&nbsp; PEST analysis

Chapter 4&nbsp;&nbsp;&nbsp;Europe Gene Editing Market Share, By Application

4.1&nbsp;&nbsp;&nbsp; Key trends in Europe gene editing, by application

4.2&nbsp;&nbsp;&nbsp; Cell line engineering

4.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.3&nbsp;&nbsp;&nbsp; Animal genetic engineering

4.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.4&nbsp;&nbsp;&nbsp; Plant genetic engineering

4.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

4.5&nbsp;&nbsp;&nbsp; Others

4.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 5&nbsp;&nbsp;&nbsp;Europe Gene Editing Market Size, By Technology

5.1&nbsp;&nbsp;&nbsp; Key trends in Europe gene editing, by technology

5.2&nbsp;&nbsp;&nbsp; CRISPR/Cas9

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Zinc Finger Nucleases (ZFNs)

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.4&nbsp;&nbsp;&nbsp; TALENs

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

5.5&nbsp;&nbsp;&nbsp; Others

5.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Europe Gene Editing Market Growth, By End-user

6.1&nbsp;&nbsp;&nbsp; Key trends in Europe gene editing, by end-user

6.2&nbsp;&nbsp;&nbsp; Biotech and Pharma Companies

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Contract Research Organizations (CROs)

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Research Institutes

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by country, 2015 - 2026 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Europe Gene Editing Market Forecast, By Country

7.1&nbsp;&nbsp;&nbsp; Key trends in Europe gene editing, by country

7.2&nbsp;&nbsp;&nbsp; UK

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.2.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.2.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Germany

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.3.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.3.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.4&nbsp;&nbsp;&nbsp; France

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.4.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.4.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.5&nbsp;&nbsp;&nbsp; Spain

7.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.5.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.5.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.6&nbsp;&nbsp;&nbsp; Russia

7.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.6.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.6.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.7&nbsp;&nbsp;&nbsp; Italy

7.7.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.7.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.7.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.8&nbsp;&nbsp;&nbsp; Poland

7.8.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.8.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.8.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.9&nbsp;&nbsp;&nbsp; The Netherlands

7.9.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.9.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.9.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

7.10&nbsp;&nbsp;&nbsp; Sweden

7.10.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, by application, 2015 - 2026 (USD Million)

7.10.2&nbsp;&nbsp;&nbsp; Market estimates and forecast, by technology, 2015 - 2026 (USD Million)

7.10.3&nbsp;&nbsp;&nbsp; Market estimates and forecast, by end-user, 2015 - 2026 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Company Profiles

8.1&nbsp;&nbsp;&nbsp; Addgene, Inc.

8.1.1&nbsp;&nbsp;&nbsp; Business overview

8.1.2&nbsp;&nbsp;&nbsp; Financial data

8.1.3&nbsp;&nbsp;&nbsp; Product landscape

8.1.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.2&nbsp;&nbsp;&nbsp; Agilent Technologies, Inc.

8.2.1&nbsp;&nbsp;&nbsp; Business overview

8.2.2&nbsp;&nbsp;&nbsp; Financial data

8.2.3&nbsp;&nbsp;&nbsp; Product landscape

8.2.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.3&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories

8.3.1&nbsp;&nbsp;&nbsp; Business overview

8.3.2&nbsp;&nbsp;&nbsp; Financial data

8.3.3&nbsp;&nbsp;&nbsp; Product landscape

8.3.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.4&nbsp;&nbsp;&nbsp; Beam Therapeutics

8.4.1&nbsp;&nbsp;&nbsp; Business overview

8.4.2&nbsp;&nbsp;&nbsp; Financial data

8.4.3&nbsp;&nbsp;&nbsp; Product landscape

8.4.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.5&nbsp;&nbsp;&nbsp; Bluebird bio, Inc.

8.5.1&nbsp; &nbsp; Business overview

8.5.2&nbsp;&nbsp;&nbsp; Financial data

8.5.3&nbsp;&nbsp;&nbsp; Product landscape

8.5.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.6&nbsp;&nbsp;&nbsp; Caribou Biosciences, Inc.

8.6.1&nbsp; &nbsp; Business overview

8.6.2&nbsp;&nbsp;&nbsp; Financial data

8.6.3&nbsp;&nbsp;&nbsp; Product landscape

8.6.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.7&nbsp;&nbsp;&nbsp; CRISPR Therapeutics

8.7.1&nbsp; &nbsp; Business overview

8.7.2&nbsp;&nbsp;&nbsp; Financial data

8.7.3&nbsp;&nbsp;&nbsp; Product landscape

8.7.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.8&nbsp;&nbsp;&nbsp; EMD Millipore (Merck KGaA)

8.8.1&nbsp; &nbsp; Business overview

8.8.2&nbsp;&nbsp;&nbsp; Financial data

8.8.3&nbsp;&nbsp;&nbsp; Product landscape

8.8.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.9&nbsp;&nbsp;&nbsp; GeneCopoeia

8.9.1&nbsp; &nbsp; Business overview

8.9.2&nbsp;&nbsp;&nbsp; Financial data

8.9.3&nbsp;&nbsp;&nbsp; Product landscape

8.9.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.10&nbsp;&nbsp;&nbsp; GenScript Corporation

8.10.1&nbsp; &nbsp; Business overview

8.10.2&nbsp;&nbsp;&nbsp; Financial data

8.10.3&nbsp;&nbsp;&nbsp; Product landscape

8.10.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.11&nbsp;&nbsp;&nbsp; Horizon Discovery Ltd

8.11.1&nbsp; &nbsp; Business overview

8.11.2&nbsp;&nbsp;&nbsp; Financial data

8.11.3&nbsp;&nbsp;&nbsp; Product landscape

8.11.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.12&nbsp;&nbsp;&nbsp; Integrated DNA Technologies Inc.

8.12.1&nbsp; &nbsp; Business overview

8.12.2&nbsp;&nbsp;&nbsp; Financial data

8.12.3&nbsp;&nbsp;&nbsp; Product landscape

8.12.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.13&nbsp;&nbsp;&nbsp; Origene Technologies

8.13.1&nbsp;&nbsp;&nbsp; Business overview

8.13.2&nbsp;&nbsp;&nbsp; Financial data

8.13.3&nbsp;&nbsp;&nbsp; Product landscape

8.13.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.14&nbsp;&nbsp;&nbsp; Precision Biosciences

8.14.1&nbsp; &nbsp; Business overview

8.14.2&nbsp;&nbsp;&nbsp; Financial data

8.14.3&nbsp;&nbsp;&nbsp; Product landscape

8.14.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.15&nbsp;&nbsp;&nbsp; Takara Bio Inc.

8.15.1&nbsp;&nbsp;&nbsp; Business overview

8.15.2&nbsp;&nbsp;&nbsp; Financial data

8.15.3&nbsp;&nbsp;&nbsp; Product landscape

8.15.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.16&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific

8.16.1&nbsp;&nbsp;&nbsp; Business overview

8.16.2&nbsp;&nbsp;&nbsp; Financial data

8.16.3&nbsp;&nbsp;&nbsp; Product landscape

8.16.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.17&nbsp;&nbsp;&nbsp; Editas Medicine

8.17.1&nbsp;&nbsp;&nbsp; Business overview

8.17.2&nbsp;&nbsp;&nbsp; Financial data

8.17.3&nbsp;&nbsp;&nbsp; Product landscape

8.17.4&nbsp;&nbsp;&nbsp; Strategic outlook

8.18&nbsp;&nbsp;&nbsp; Intellia Therapeutics

8.18.1&nbsp;&nbsp;&nbsp; Business overview

8.18.2&nbsp;&nbsp;&nbsp; Financial data

8.18.3&nbsp;&nbsp;&nbsp; Product landscape

&nbsp;

Request sample

Need Help?

Contact us

Get In Touch

Address

Contact

Phone :

Email:

Company

Information

Links